Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Xetra
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

QIA:GR

20.555 EUR 0.137 0.66%

As of 13:52:31 ET on 01/29/2015.

Snapshot for QIAGEN NV (QIA)

Open: 20.530 Day's Range: 20.000 - 20.600 Volume: 856,574
Previous Close: 20.692 52wk Range: 14.031 - 21.130 1-Yr Rtn: +24.61%

Stock Chart for QIA

No chart data available.
  • QIA:GR 20.555
  • 1D
  • 1M
  • 1Y
20.692
Interactive QIA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for QIA

Current P/E Ratio (ttm) 51.2239
Estimated P/E(12/2015) 19.9727
Relative P/E vs. DAX 3.4334
Earnings Per Share (USD) (ttm) 0.4491
Est. EPS (USD) (12/2015) 1.1520
Est. PEG Ratio 2.0770
Market Cap (M EUR) 4,886.43
Shares Outstanding (M) 239.71
30 Day Average Volume 526,595
Price/Book (mrq) 2.0052
Price/Sale (ttm) 4.0957
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/05/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for QIA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for QIA

QIAGEN N.V. provides sample and assay technologies. The Company's technologies (in the format of consumables and automated solutions) are used to process biological samples and to analyze analytes contained therein, such as DNA and RNA. QIAGEN provides these technologies to customers conducting molecular diagnostics, applied testing, pharmaceutical R&D and academic research.

Peer M SchatzCEO/Managing DirectorRoland SackersCFO/Managing Director
Dietrich HauffeSenior VP:Life Sciences BusDouglas LiuSenior VP:Global Operations
More Company Profile & Key Executives for QIA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
  • QIA News

  • Industry News

No stories found
No stories found
Advertisement
Sponsored Links
Advertisements
sec ||= nil